- Home
- ENVB vs TAOP Comparison
ENVB vs TAOP Comparison
Compare ENVB & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- TAOP
- Stock Information
- Founded
- ENVB 1994
- TAOP 1993
- Country
- ENVB United States
- TAOP China
- Employees
- ENVB N/A
- TAOP N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- TAOP Computer Software: Prepackaged Software
- Sector
- ENVB Health Care
- TAOP Technology
- Exchange
- ENVB Nasdaq
- TAOP Nasdaq
- Market Cap
- ENVB 3.0M
- TAOP 2.9M
- IPO Year
- ENVB N/A
- TAOP N/A
- Fundamental
- Price
- ENVB $6.70
- TAOP $2.47
- Analyst Decision
- ENVB Strong Buy
- TAOP
- Analyst Count
- ENVB 1
- TAOP 0
- Target Price
- ENVB $10.00
- TAOP N/A
- AVG Volume (30 Days)
- ENVB 63.7K
- TAOP 284.2K
- Earning Date
- ENVB 11-13-2025
- TAOP 12-08-2025
- Dividend Yield
- ENVB N/A
- TAOP N/A
- EPS Growth
- ENVB N/A
- TAOP N/A
- EPS
- ENVB N/A
- TAOP N/A
- Revenue
- ENVB N/A
- TAOP $36,196,786.00
- Revenue This Year
- ENVB N/A
- TAOP N/A
- Revenue Next Year
- ENVB N/A
- TAOP N/A
- P/E Ratio
- ENVB N/A
- TAOP N/A
- Revenue Growth
- ENVB N/A
- TAOP N/A
- 52 Week Low
- ENVB $6.63
- TAOP $1.81
- 52 Week High
- ENVB $99.00
- TAOP $24.75
- Technical
- Relative Strength Index (RSI)
- ENVB 89.48
- TAOP 39.49
- Support Level
- ENVB $0.59
- TAOP $2.27
- Resistance Level
- ENVB $7.51
- TAOP $2.80
- Average True Range (ATR)
- ENVB 0.17
- TAOP 0.28
- MACD
- ENVB 0.63
- TAOP -0.01
- Stochastic Oscillator
- ENVB 88.33
- TAOP 48.53
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.